GUTS
Fractyl Health, Inc.
Fractyl Health, Inc. insider trading
Insiders at Fractyl Health, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Bradley William (Director) buying $39.9K of GUTS, filed Sep 16, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $39.9K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 14, 2026
From SEC filings · last 30 days
Recent GUTS insider transactions
Bradley WilliamDirector
Bought 64,516 sh at $0.62 · Sep 14, 2026
$39.9K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
GUTS insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded GUTS on the open market: 11 purchases worth $250.7K and 7 sales worth $874.2K, 4 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 6 purchases ($147.1K) and 0 sales, by 5 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$127.2K5 buys | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$20K1 buy | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | +$103.5K5 buys | −$288.7K4 sales · all on a plan | |
| Q4 2024 | — | −$397K2 sales | |
| Q3 2024 | — | −$188.5K1 sale |
- Largest purchase
- +$50K of GUTS by Bradley William (Director) on Jun 10, 2026.
- Largest sale
- −$238.4K of GUTS by Rajagopalan Harith (Chief Executive Officer · Director) on Nov 11, 2024.
Open-market transactions through Jun 30, 2026most recent first
Royan Ajay
Director
+$19.6K
Jun 12, 2026
23,000 sh · $0.85
Bradley William
Director
+$50K
Jun 10, 2026
68,493 sh · $0.73
Sheffield Ian
Director
+$25.6K
Jun 10, 2026
35,000 sh · $0.73
Rajagopalan Harith
Chief Executive Officer · Director
+$18.3K
Jun 10, 2026
25,000 sh · $0.73
Smith Weber Lara
Chief Financial Officer
+$13.8K
Jun 08, 2026
20,000 sh · $0.69
Rajagopalan Harith
Chief Executive Officer · Director
+$20K
Dec 04, 2025
10,416 sh · $1.92
Barnes Kelly Ann
Director
+$40.3K
Mar 14, 2025
31,000 sh · $1.30
Royan Ajay
Director · 10% Owner
+$22.9K
Mar 14, 2025
17,901 sh · $1.28
Bradley William
Director
+$20.3K
Mar 13, 2025
16,129 sh · $1.26
Schulman Amy W
Director
+$10K
Mar 13, 2025
8,550 sh · $1.17
Conaway Samuel
Director
+$10K
Mar 13, 2025
8,550 sh · $1.17
Rajagopalan Harith10b5-1
Chief Executive Officer · Director
−$165.6K
Jan 31, 2025
90,972 sh · $1.82
Caplan Jay David10b5-1
President, Chief Product Off.
−$40.4K
Jan 31, 2025
22,346 sh · $1.81
Caplan Jay David10b5-1
President, Chief Product Off.
−$41.9K
Jan 30, 2025
21,472 sh · $1.95
Rajagopalan Harith10b5-1
Chief Executive Officer · Director
−$40.8K
Jan 30, 2025
20,948 sh · $1.95
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Royan AjayDirector | 23,000 | $0.85 | +$19.6K |
| Jun 10, 2026 | Bradley WilliamDirector | 68,493 | $0.73 | +$50K |
| Jun 10, 2026 | Sheffield IanDirector | 35,000 | $0.73 | +$25.6K |
| Jun 10, 2026 | Rajagopalan HarithChief Executive Officer · Director | 25,000 | $0.73 | +$18.3K |
| Jun 08, 2026 | Smith Weber LaraChief Financial Officer | 20,000 | $0.69 | +$13.8K |
| Dec 04, 2025 | Rajagopalan HarithChief Executive Officer · Director | 10,416 | $1.92 | +$20K |
| Mar 14, 2025 | Barnes Kelly AnnDirector | 31,000 | $1.30 | +$40.3K |
| Mar 14, 2025 | Royan AjayDirector · 10% Owner | 17,901 | $1.28 | +$22.9K |
| Mar 13, 2025 | Bradley WilliamDirector | 16,129 | $1.26 | +$20.3K |
| Mar 13, 2025 | Schulman Amy WDirector | 8,550 | $1.17 | +$10K |
| Mar 13, 2025 | Conaway SamuelDirector | 8,550 | $1.17 | +$10K |
| Jan 31, 2025 | Rajagopalan Harith10b5-1Chief Executive Officer · Director | 90,972 | $1.82 | −$165.6K |
| Jan 31, 2025 | Caplan Jay David10b5-1President, Chief Product Off. | 22,346 | $1.81 | −$40.4K |
| Jan 30, 2025 | Caplan Jay David10b5-1President, Chief Product Off. | 21,472 | $1.95 | −$41.9K |
| Jan 30, 2025 | Rajagopalan Harith10b5-1Chief Executive Officer · Director | 20,948 | $1.95 | −$40.8K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check GUTS — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Fractyl Health, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are GUTS insiders buying or selling?
- Between Sep 14, 2026 and Sep 14, 2026, 1 Fractyl Health, Inc. insider made 1 open-market purchase worth $39.9K and no sales, a net purchase of $39.9K.
- How much GUTS stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 9 Fractyl Health, Inc. insiders made 11 open-market purchases worth $250.7K and 7 sales worth $874.2K. 4 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 6 purchases ($147.1K) and no sales. The largest purchase was Bradley William buying $50K on Jun 10, 2026. The largest sale was Rajagopalan Harith selling $238.4K on Nov 11, 2024.
- What was the largest recent GUTS insider trade?
- Bradley William (Director) bought $39.9K of GUTS stock on Sep 14, 2026 at about $0.62 a share.
- When did an insider last buy GUTS shares?
- The most recent open-market purchase on file is Bradley William (Director) buying $39.9K on Sep 14, 2026.
- Where does GUTS insider trading data come from?
- From the Form 4 filings Fractyl Health, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.